
Marcus & Millichap, Inc. Reports Results for Fourth Quarter and Full Year 2024
Marcus & Millichap, Inc. (the 'Company', 'Marcus & Millichap', or 'MMI') (NYSE: MMI), a leading national real estate services firm specializing in commercial real estate investment sales, financing, research and advisory services, reported its fourth quarter and full year 2024 financial results today.
Fourth Quarter 2024 Highlights Compared to Fourth Quarter 2023
Total revenue of $240.1 million, compared to $166.2 million
Brokerage commissions of $202.8 million, compared to $144.6 million
Private Client Market brokerage revenue of $120.4 million, compared to $94.8 million
Middle Market and Larger Transaction Market brokerage revenue of $76.7 million, compared to $44.1 million
Financing fees of $31.2 million, compared to $15.9 million
Net income of $8.5 million, or $0.22 per common share, diluted, compared to net loss of $10.2 million, or $0.27 loss per common share, diluted
Adjusted EBITDA 1 of $18.0 million, compared to $(4.5) million
Full Year 2024 Highlights Compared to Full Year 2023
Total revenue of $696.1 million, compared to $645.9 million
Brokerage commissions of $589.7 million, compared to $559.8 million
Private Client Market brokerage revenue of $365.8 million, compared to $373.0 million
Middle Market and Larger Transaction Market brokerage revenue of $202.8 million, compared to $165.9 million
Financing fees of $84.5 million, compared to $66.9 million
Net loss of $12.4 million, or $0.32 loss per common share, diluted, compared to net loss of $34.0 million, or $0.88 loss per common share, diluted
Adjusted EBITDA 1 of $9.4 million, compared to $(19.6) million
'We are pleased to report an exceptionally strong fourth quarter, achieving our highest quarterly revenue in two years. Our performance was driven by our efforts to increase exclusive inventory and elevate client outreach throughout the year and a favorable interest rate environment in the Fall of 2024 that spurred transactions. It also underscores the positive benefits of our strategic initiatives and the resilience of our business model,' stated Hessam Nadji, Marcus & Millichap's president and chief executive officer.
Mr. Nadji continued, 'Looking forward, while we believe that price adjustments and higher motivations to transact will continue to result in increased transaction activity year over year, we continue to face the headwind of higher and still-volatile interest rates. Our focus remains on increasing client outreach, investing in experienced talent and raising the production levels of our existing salesforce. Strategic acquisitions and an ongoing focus on technology and further adoption of A.I. are also key priorities in our quest to maximize long-term shareholder value.'
_________________________________
1 Please refer to the reconciliation of GAAP measures to non-GAAP measures at the end of this release for more information.
Fourth Quarter 2024 Results Compared to Fourth Quarter 2023
Total revenue for the fourth quarter 2024 was $240.1 million, an increase of 44.4% compared to $166.2 million for the fourth quarter 2023.
For real estate brokerage commissions, revenue was $202.8 million, an increase of 40.3% compared to the same period in the prior year. The increase was primarily attributed to a 40.8% increase in total sales volume compared to the fourth quarter 2023. Private Client Market revenue increased by 27.0%, and the combined Middle Market and Larger Transaction Market revenue increased by 74.0%.
For financing fees, revenue was $31.2 million, an increase of 96.6% compared to the same period in the prior year. The increase was primarily attributed to a 139.4% increase in total financing volume, partially offset by a 17 basis point decrease in the average fee rate earned, compared to the fourth quarter 2023.
Total operating expenses for the fourth quarter 2024 were $233.4 million compared to $183.4 million for the same period in the prior year. The change was primarily due to an increase of $46.3 million in cost of services. Cost of services as a percentage of total revenue decreased by 20 basis points to 63.2% compared to the same period during the prior year primarily due to our senior investment sales and financing professionals earning a lower amount of additional commissions.
Selling, general and administrative expenses for the fourth quarter 2024 were $76.3 million compared to $74.7 million for the same period in 2023. The increase was primarily due to an increase in personnel costs, partially offset by a reduction in marketing support provided to our investment sales and financing professionals.
Net income for the fourth quarter 2024 was $8.5 million, or $0.22 per common share, diluted, compared to a net loss of $10.2 million, or $0.27 loss per common share, diluted, for the same period in 2023. Adjusted EBITDA for the fourth quarter 2024 was $18.0 million, compared to $(4.5) million for the same period in the prior year, primarily as a result of the increase in operating income.
Full Year 2024 Results Compared to Full Year 2023
Total revenue for 2024 was $696.1 million compared to $645.9 million for 2023, an increase of $50.1 million, or 7.8%. Total operating expenses for 2024 increased by 3.4% to $729.0 million compared to $705.3 million for 2023. Cost of services as a percent of total revenues decreased to 62.0%, down 100 basis points compared to 2023. The Company's net loss for 2024 was $12.4 million, or $0.32 loss per common share, diluted, compared to a net loss of $34.0 million, or $0.88 loss per common share, diluted, for 2023. Adjusted EBITDA for 2024 increased to $9.4 million from $(19.6) million for 2023. As of December 31, 2024, the Company had 1,712 investment sales and financing professionals, compared to 1,783 at the end of 2023.
Capital Allocation
During the twelve months ended December 31, 2024, the Company declared two semi-annual regular dividends aggregating $20.3 million and repurchased 16,900 shares of common stock for an aggregate purchase price of $0.6 million.
After accounting for shares repurchased through February 11, 2025, the Company has approximately $70.5 million authorized to repurchase shares under its share repurchase program. No time limit has been established for the completion of the program, and the repurchases are expected to be executed from time-to-time, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans.
Business Outlook
Notwithstanding the ongoing price discovery and wider than normal bid/ask spreads, the commercial real estate transaction market is poised over the long term to overcome the near-term challenges which are currently expected to extend for the first half of 2025. Accordingly, the Company believes it remains well-positioned to achieve long-term growth.
The Company benefits from its experienced management team, infrastructure investments, industry-leading market research and proprietary technology. The size and fragmentation of the Private Client Market continues to offer long-term growth opportunities through consolidation. This highly fragmented market segment consistently accounts for over 80% of all commercial property sales transactions and over 60% of the commission pool. The top 10 brokerage firms led by MMI have an estimated 20% share of this segment by transaction count.
Key factors that may influence the Company's business during 2025 include:
Volatility in transactional activity and investor sentiment driven by:
The elevated cost of debt capital
Interest rate uncertainty, the potential for rising inflation and the heightened bid-ask spread between buyers and sellers
Risks of a potential recession and its unfavorable impact to CRE space demand
Possible impact to market sentiment related to the new administration's potential tariff, immigration and other policy changes which may influence transaction velocity and/or future fluctuations in interest rates, sales and financing activity
Increase in operating expenses driven by labor costs, insurance, taxes and construction materials
Volatility in each of the Company's markets
Increase in costs related to in-person events, client meetings, and conferences
Global geopolitical uncertainty, which may cause investors to refrain from transacting
The potential for acquisition activity and subsequent integration
Webcast and Call Information
Marcus & Millichap will host a live webcast today to discuss the financial results at 7:30 a.m. Pacific Time/10:30 a.m. Eastern Time. The webcast will be accessible through the Investor Relations section of Marcus & Millichap's website at ir.marcusmillichap.com and will be archived upon completion of the call. The Company encourages the use of the webcast due to potential extended wait times to access the conference call via dial-in.
For those unable to access the webcast, callers from the United States and Canada should dial 1-877-407-9208 ten minutes prior to the scheduled call time. International callers should dial 1-201-493-6784.
Replay Information
For those unable to participate during the live broadcast, a telephonic replay of the call will also be available from 1:30 p.m. Eastern Time on Friday, February 14, 2025 through 11:59 p.m. Eastern Time on Friday, February 28, 2025 by dialing 1-844-512-2921 in the United States and Canada or 1-412-317-6671 internationally and entering passcode 13750435.
About Marcus & Millichap, Inc.
Marcus & Millichap, Inc. is a leading national real estate services firm specializing in commercial real estate investment sales, financing services, research and advisory services. As of December 31, 2024, the Company had 1,712 investment sales and financing professionals in more than 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The Company also offers market research, consulting and advisory, and leasing services to our clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
This release includes forward-looking statements, including our expectations regarding the long-term outlook of the commercial real estate transaction market, and our positioning within it, our belief relating to the Company's long-term growth, our assessment of the key factors influencing the Company's business outlook, including the expectation for future interest rates and likely impact of potential rate cuts on commercial real estate demand, and the execution of our capital return program, including a semi-annual dividend and stock repurchase program. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:
general uncertainty in the capital markets, a worsening of economic conditions, and the rate and pace of economic recovery following an economic downturn;
changes in our business operations;
market trends in the commercial real estate market or the general economy, including the impact of inflation and changes to interest rates;
our ability to attract and retain qualified senior executives, managers, and investment sales and financing professionals;
the impact of forgivable loans and related expense resulting from the recruitment and retention of agents;
the effects of increased competition on our business;
our ability to successfully enter new markets or increase our market share;
our ability to successfully expand our services and businesses and to manage any such expansions;
our ability to retain existing clients and develop new clients;
our ability to keep pace with changes in technology;
any business interruption or technology failure, including cybersecurity risks and ransomware attacks, and any related impact on our reputation;
changes in interest rates, availability of capital, tax laws, employment laws, or other government regulation affecting our business, in each case as may be impacted by the new U.S. administration;
our ability to successfully identify, negotiate, execute, and integrate accretive acquisitions; and
other risk factors included under 'Risk Factors' in our most recent Annual Report on Form 10-K.
In addition, in this release, the words 'believe,' 'may,' 'will,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'goal,' 'expect,' 'predict,' 'potential,' 'should' and similar expressions, as they relate to our Company, our business and our management, are intended to identify forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements.
Forward-looking statements speak only as of the date of this release. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. We have not filed our Form 10-K for the year ended December 31, 2024. As a result, all financial results described in this earnings release should be considered preliminary, and are subject to change to reflect any necessary adjustments or changes in accounting estimates, that are identified prior to the time we file our Form 10-K.
MARCUS & MILLICHAP, INC.
KEY OPERATING METRICS SUMMARY
(Unaudited)
Total sales volume was approximately $18.4 billion for the three months ended December 31, 2024, encompassing 2,485 transactions consisting of $12.3 billion for real estate brokerage (1,742 transactions), $3.5 billion for financing (425 transactions) and $2.6 billion in other transactions, including consulting and advisory services (318 transactions). Total sales volume was $49.6 billion for the year ended December 31, 2024, encompassing 7,836 transactions consisting of $33.6 billion for real estate brokerage (5,447 transactions), $9.1 billion for financing (1,249 transactions) and $6.9 billion in other transactions, including consulting and advisory services (1,140 transactions). As of December 31, 2024, the Company had 1,610 investment sales professionals and 102 financing professionals. Key metrics for real estate brokerage and financing activities (excluding other transactions) are as follows:
Three Months Ended
December 31,
Years Ended
December 31,
Real Estate Brokerage
2024
2023
2024
2023
Average Number of Investment Sales Professionals
1,593
1,705
1,610
1,744
Average Number of Transactions per Investment Sales Professional
1.09
0.83
3.38
3.14
Average Commission per Transaction
$
116,433
$
102,306
$
108,261
$
102,238
Average Commission Rate
1.65
%
1.66
%
1.75
%
1.82
%
Average Transaction Size (in thousands)
$
7,045
$
6,168
$
6,174
$
5,630
Total Number of Transactions
1,742
1,413
5,447
5,475
Total Sales Volume (in millions)
$
12,273
$
8,716
$
33,630
$
30,823
Three Months Ended
December 31,
Years Ended
December 31,
Financing (1)
2024
2023
2024
2023
Average Number of Financing Professionals
103
98
101
96
Average Number of Transactions per Financing Professional
4.13
2.42
12.37
11.21
Average Fee per Transaction
$
59,219
$
54,468
$
52,955
$
50,677
Average Fee Rate
0.72
%
0.89
%
0.73
%
0.81
%
Average Transaction Size (in thousands)
$
8,184
$
6,133
$
7,283
$
6,254
Total Number of Transactions
425
237
1,249
1,076
Total Financing Volume (in millions)
$
3,478
$
1,453
$
9,096
$
6,729
(1)
Operating metrics exclude certain financing fees not directly associated to transactions.
The following table sets forth the number of transactions, sales volume and revenue by commercial real estate market for real estate brokerage:
Three Months Ended December 31,
2024
2023
Change
Real Estate Brokerage
Number
Volume
Revenue
Number
Volume
Revenue
Number
Volume
Revenue
(in millions)
(in thousands)
(in millions)
(in thousands)
(in millions)
(in thousands)
<$1 million
223
$
118
$
5,735
209
$
125
$
5,680
14
$
(7
)
$
55
Private Client Market
($1 – <$10 million)
1,280
4,276
120,364
1,043
3,447
94,772
237
829
25,592
Middle Market
($10 – <$20 million)
118
1,651
30,556
85
1,194
19,567
33
457
10,989
Larger Transaction
Market (≥$20 million)
121
6,228
46,172
76
3,950
24,540
45
2,278
21,632
1,742
$
12,273
$
202,827
1,413
$
8,716
$
144,559
329
$
3,557
$
58,268
Years Ended December 31,
2024
2023
Change
Real Estate Brokerage
Number
Volume
Revenue
Number
Volume
Revenue
Number
Volume
Revenue
(in millions)
(in thousands)
(in millions)
(in thousands)
(in millions)
(in thousands)
<$1 million
819
$
446
$
21,034
809
$
483
$
20,894
10
$
(37
)
$
140
Private Client Market
($1 – <$10 million)
3,967
12,802
365,837
4,097
13,616
372,979
(130
)
(814
)
(7,142
)
Middle Market
($10 – <$20 million)
344
4,764
84,186
303
4,117
73,007
41
647
11,179
Larger Transaction
Market (≥$20 million)
317
15,618
118,638
266
12,607
92,872
51
3,011
25,766
5,447
$
33,630
$
589,695
5,475
$
30,823
$
559,752
(28
)
$
2,807
$
29,943
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for shares and par value)
(Unaudited)
December 31,
2024
2023
Assets
Current assets:
Cash, cash equivalents, and restricted cash
$
153,445
$
170,753
Commissions receivable
18,804
16,171
Prepaid expenses
9,311
8,813
Income tax receivable
6,030
9,299
Marketable debt securities, available-for-sale (amortized cost of $189,667 and $169,018
at December 31, 2024 and December 31, 2023, respectively, and $0 allowance for
credit losses)
189,667
168,881
Advances and loans, net
17,519
3,574
Other assets, current
15,543
16,203
Total current assets
410,319
393,694
Property and equipment, net
26,139
27,450
Operating lease right-of-use assets, net
81,120
90,058
Marketable debt securities, available-for-sale (amortized cost of $52,366 and $69,538 at
December 31, 2024 and December 31, 2023, respectively, and $0 allowance for credit
losses)
51,147
67,459
Assets held in rabbi trust
12,191
10,838
Deferred tax assets, net
48,080
46,930
Goodwill and other intangible assets, net
43,521
51,183
Advances and loans, net
173,657
175,827
Other assets, non-current
23,626
14,972
Total assets
$
869,800
$
878,411
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued expenses
$
13,737
$
8,126
Deferred compensation and commissions
67,197
55,769
Operating lease liabilities
18,522
18,336
Accrued bonuses and other employee related expenses
25,485
19,119
Other liabilities, current
8,076
3,919
Total current liabilities
133,017
105,269
Deferred compensation and commissions
33,257
47,771
Operating lease liabilities
65,701
69,407
Other liabilities, non-current
7,007
10,690
Total liabilities
238,982
233,137
Commitments and contingencies
—
—
Stockholders' equity:
Preferred stock, $0.0001 par value:
Authorized shares – 25,000,000; issued and outstanding shares – none at December 31, 2024
and 2023, respectively
—
—
Common stock, $0.0001 par value:
Authorized shares – 150,000,000; issued and outstanding shares – 38,856,790 and
38,412,484 at December 31, 2024 and 2023, respectively
4
4
Additional paid-in capital
173,340
153,740
Retained earnings
458,907
492,298
Accumulated other comprehensive loss
(1,433
)
(768
)
Total stockholders' equity
630,818
645,274
Total liabilities and stockholders' equity
$
869,800
$
878,411
MARCUS & MILLICHAP, INC.
OTHER INFORMATION
(Unaudited)
Adjusted EBITDA Reconciliation
Adjusted EBITDA, which the Company defines as net income (loss) before (i) interest income and other, including net realized gains (losses) on marketable debt securities, available-for-sale and cash, cash equivalents, and restricted cash, (ii) interest expense, (iii) Provision (benefit) for income taxes, (iv) depreciation and amortization, and (v) stock-based compensation. The Company uses Adjusted EBITDA in its business operations to evaluate the performance of its business, develop budgets and measure its performance against those budgets, among other things. The Company also believes that analysts and investors use Adjusted EBITDA as a supplemental measure to evaluate its overall operating performance. However, Adjusted EBITDA has material limitations as a supplemental metric and should not be considered in isolation or as a substitute for analysis of the Company's results as reported under U.S. generally accepted accounting principles ('U.S. GAAP'). The Company finds Adjusted EBITDA to be a useful management metric to assist in evaluating performance, because Adjusted EBITDA eliminates items related to capital structure, taxes and non-cash items. Considering the foregoing limitations, the Company does not rely solely on Adjusted EBITDA as a performance measure and also considers its U.S. GAAP results. Adjusted EBITDA is not a measurement of the Company's financial performance under U.S. GAAP and should not be considered as an alternative to net income (loss), operating income (loss) or any other measures calculated in accordance with U.S. GAAP. Because Adjusted EBITDA is not calculated in the same manner by all companies, it may not be comparable to other similarly titled measures used by other companies.
A reconciliation of the most directly comparable U.S. GAAP financial measure, net income, to Adjusted EBITDA is as follows (in thousands):
Three Months Ended December 31,
Years Ended December 31,
2024
2023
2024
2023
Net income (loss)
$
8,548
$
(10,233
)
$
(12,362
)
$
(34,035
)
Adjustments:
Interest income and other (1)
(4,987
)
(4,689
)
(18,793
)
(17,890
)
Interest expense
201
216
812
888
Provision (benefit) for income taxes
2,947
(1,451
)
(666
)
(6,366
)
Depreciation and amortization
5,288
3,315
16,589
13,627
Stock-based compensation
6,037
8,338
23,792
24,146
Adjusted EBITDA
$
18,034
$
(4,504
)
$
9,372
$
(19,630
)
(1)
Other includes net realized gains (losses) on marketable debt securities available-for-sale.
Glossary of Terms
Private Client Market segment: transactions with values from $1 million to up to but less than $10 million
Middle Market segment: transactions with values from $10 million to up to but less than $20 million
Larger Transaction Market segment: transactions with values of $20 million and above
Certain Adjusted Metrics
Real Estate Brokerage
Following are actual and as adjusted metrics excluding any large transactions in our real estate brokerage business in excess of $300 million:
Three Months Ended
December 31, 2024
Year Ended
December 31, 2024
(actual)
(as adjusted)
(actual)
(as adjusted)
Total Sales Volume Increase
40.8
%
40.8
%
9.1
%
9.1
%
Average Commission Rate Decrease
(0.6
)%
(0.6
)%
(3.8
)%
(3.8
)%
Average Transaction Size Increase
14.2
%
14.2
%
9.7
%
9.7
%
View source version on businesswire.com: https://www.businesswire.com/news/home/20250214672105/en/
CONTACT: Investor Relations Contact:
Investor Relations
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: PROFESSIONAL SERVICES OTHER CONSTRUCTION & PROPERTY COMMERCIAL BUILDING & REAL ESTATE FINANCE CONSTRUCTION & PROPERTY CONSULTING
SOURCE: Marcus & Millichap, Inc.
Copyright Business Wire 2025.
PUB: 02/14/2025 08:00 AM/DISC: 02/14/2025 08:00 AM
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
15 minutes ago
- Yahoo
PROPOSED RTO, $35 MILLION FINANCING & CONSOLIDATION OF THE PECOY COPPER PORPHYRY PROJECT IN SOUTHERN PERU
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, June 11, 2025 /CNW/ - Priyanka Capital Inc. ("Priyanka" or the "Company") is pleased to announce that it has entered into a letter of intent with Pecoy Copper Limited, a special purpose vehicle ("Pecoy SPV") founded by the former management team of Nomad Royalty Company Ltd. The proposed transaction is intended to result in a reverse takeover of the Company by Pecoy SPV (the "RTO"). The Transaction Pecoy SPV has recently signed a series of binding acquisition and option agreements (the "Acquisition Agreements") with Copper X Mining Corp., Pembrook Copper Corp., and various private third parties to consolidate ownership of the Pecoy copper-gold-molybdenum project (the "Pecoy Project" or "Pecoy") located in southern Peru. Upon closing of the Acquisition Agreements and the RTO (the "Transaction"), the Company, to be renamed Pecoy Copper Corp. (the "Pecoy Copper"), will directly or indirectly either own, or hold an option to acquire, all of the properties comprising the Pecoy Project. Closing of the RTO is conditional upon receiving conditional approval (the "TSXV Conditional Approval") from the TSX Venture Exchange ("TSXV") for the listing of the common shares of the Company on the TSXV. As part of the Transaction, Pecoy SPV has engaged Canaccord Genuity Corp. ("Canaccord Genuity") to act as lead agent and sole bookrunner in connection with a private placement of subscription receipts for gross proceeds of approximately $35 million. Management, officers and affiliates of Pecoy Copper intend to subscribe for up to $8.5 million of the private placement. Creating A New Leading Copper-Gold Focused Development Company The Transaction would unlock the full potential of one of the world's largest undeveloped copper-gold-molybdenum porphyry deposits by consolidating its ownership for the first time. The benefits of this transaction to the Company are expected to include the following: Pecoy Copper represents a rare opportunity to acquire one of the world's largest undeveloped copper-gold-molybdenum porphyry deposits, with an Inferred Mineral Resource of approximately 865 million tonnes grading 0.34% Cu, 0.012% Mo, 0.05 g/t Au, and 1.33 g/t Ag; containing 6.5 billion pounds of copper and offering substantial resource expansion potential. The Pecoy Project has over US$65 million in historical investment since its discovery in 2011 that supports the potential for a large-scale, low-strip, open-pit operation at a favorable low elevation of 1,650 metres above sea level. Significant exploration upside exists not only at Pecoy but also across more than 19,772 hectares of surrounding concessions, including the Tororume Project, with multiple early and advanced-stage targets already identified. To date, only 48,576 metres of diamond drilling have been completed at Pecoy, with near-term priority targets in the center of the pit and south breccia zones. Initial metallurgical testing indicates a high copper recovery rate of 88%, with no deleterious elements detected. Further testwork will assess the potential to produce a molybdenum concentrate through Cu-Mo separation. The project benefits from robust infrastructure and long-term community agreements, including a 30-year surface access agreement with local communities, active drill permits, and an operational exploration camp — all of which support near-term drilling and development efforts. Peru is a top-tier mining jurisdiction, consistently ranked among the world's leading producers of copper, gold, silver, tin and zinc. Mining is a key contributor to the country's GDP and the global supply of metals. Strategically located within the Southern Peru Porphyry Copper Belt, Pecoy sits at the northwestern end of a district that hosts world-class deposits such as Cerro Verde, Cuajone, Toquepala, Quellaveco, Zafranal, and Cerro Negro, making it ideally positioned for rapid advancement. Proceeds from the upcoming financing will be used to complete 30,000 metres of exploration drilling, conduct metallurgical and geotechnical studies, and advance the Pecoy Project toward a Preliminary Economic Assessment (PEA). The Offering Pecoy SPV has entered into an engagement letter with Canaccord Genuity to act as lead agent and sole bookrunner, on its own behalf and on behalf of a syndicate of agents (collectively, the "Agents"), in connection with an offering of subscription receipts (the "Subscription Receipts") at a price of $0.60 per Subscription Receipt (the "Offering Price") for gross proceeds of approximately $35 million (the "Offering"). The Offering shall be conducted on a "best efforts" private placement basis. Pecoy SPV has also granted the Agents an option (the "Agents' Option") to sell up to such number of additional Subscription Receipts as is equal to 15% of the number of Subscription Receipts sold under the Offering at the Offering Price. The Agents' Option shall be exercisable, in whole or in part, at any time up to 48 hours prior to closing of the Offering. Upon closing of the Offering, the gross proceeds of the Offering, less certain payments to the Agents on account of their expenses and partial commission, shall be held in escrow until certain conditions are met, including receipt of the TSXV Conditional Approval and the satisfaction of all conditions to closing of the Acquisition Agreements. Each Subscription Receipt shall be automatically exchanged for, without payment of any additional consideration and without further action on the part of the holder thereof, one common share of Pecoy SPV upon satisfaction of the escrow release conditions prior to the date that is 90 days following the Offering closing date. Upon closing of the RTO, all Pecoy SPV shares, including the shares issuable under the Subscription Receipts, shall be exchanged for shares of Pecoy Copper. Additional details of the Offering shall be announced upon closing of the Offering. The net proceeds of the Offering shall be used to fund the cash consideration in connection with the Acquisition Agreements, advance exploration and development of the Pecoy Copper Project, as well as for working capital and general corporate purposes. The completion of the foregoing transactions is subject to a number of closing conditions, including shareholder approval in certain circumstances and the receipt of the TSXV Conditional Approval. "Pecoy Copper is a rare opportunity to unlock one of the world's largest undeveloped copper-gold-molybdenum systems," said Vincent Metcalfe, CEO, Director and Co-Founder of Pecoy Copper. "With a large-scale resource already defined, exceptional exploration potential, and long-term community agreements in place, we are well positioned to accelerate development. Pecoy Copper is set to play a meaningful role in Peru's mining future and the global copper supply chain. We're thrilled to launch this new chapter with the strong support of all our stakeholders." "Having worked in Peru for over 10 years, I, like Mr. Metcalfe, have continuously sought 'The Project' that combines established value, scale, exploration potential, and a clear development roadmap," commented Paul Matysek, Chairman and Co-Founder of Pecoy Copper. "Historically, the advancement of the project has been hampered by fractured ownership, but uniting both parts of the deposit for the first time is a major milestone that clears the way for further development. Our experienced team, an established resource with significant upside, a 30-year community agreement, and proximity to infrastructure, are key elements that will propel Pecoy Copper to success." Pecoy Copper Board and Management Upon closing of the Transaction, the management and board of the Company shall be reconstituted to lead the development of the Pecoy Project. The board will consist of Paul Matysek (Chair), Luis Zapata, Vincent Metcalfe, Jerrold Annett, Jose Luque and two additional nominees to be determined. The management team will be led by Vincent Metcalfe as President and CEO and will include Vincent Cardin-Tremblay as Chief Geological Officer and Luis Zapata as Managing Director (Peru) in addition to other management appointments to be determined. Vincent Metcalfe – President, CEO & DirectorAccomplished senior executive with over 20 years of experience building companies and advancing mining projects. Brings deep expertise in M&A, financial management, and raising capital. Co-Founder of Evolve Royalties and former CEO and Chair of Nomad Royalty, sold to Sandstorm. Recipient of the YMP Peter Munk Award for leadership and innovation in mining. Paul Matysek – ChairmanSerial entrepreneur, M&A specialist, and geologist with over 40 years of experience in the mining industry. Since 2007 as CEO or Chairman, Mr. Matysek has sold six publicly listed companies, in aggregate worth over $3 billion, with two assets going into commercial production: Bethune Mine - Potash One and Lindero Mine - Goldrock Mines. Most recently, he was the CEO of Gold X Mining Corp. that was sold to Grand Columbia Gold Corp. for approximately $365 million. Mr. Matysek is a recipient of the EY Entrepreneur of the Year for Mining & Resources. Vincent Cardin-Tremblay – Chief Geological OfficerAccomplished geologist with extensive exploration and mining experience across the Americas and Africa. Served as VP–Geology at Nomad Royalty Company prior to its acquisition by Sandstorm Gold. He has also held senior technical roles at Harte Gold, Golden Star, and IAMGOLD, and worked with Freeport-McMoRan and Glencore. Luis Zapata – Managing Director – Peru, DirectorFinance and mining executive with 15 years of experience in resource development. Mr. Zapata has financed and operated numerous mining and energy projects. Currently serves as CEO of a private Peruvian gold producer, and as President & Director of Axcap Ventures. Held senior roles including Head of Latin American Equities at Canaccord Genuity. Jerrold Annett – DirectorGlobal mining and capital markets specialist, and metallurgist with 29+ years of experience in mining. Most recently responsible for leading Capstone Copper's investor relations, marketing and metal sales activities. Worked at Teck Resources and Falconbridge as a metallurgist and in metal sales, followed by 10 years in capital markets, including with Scotiabank where he was Head of Mining Institutional Sales. He is a P. Eng. and has a Bachelor of Applied Science in Mining and Mineral Engineering from Queen's University. Jose Luque – DirectorSenior executive with over 30 years of experience building shareholder value. Possesses profound insights in mining operations, M&A, organizational leadership, project management, financial management and restructuring. Serves as CEO of Gea Mining which promotes the development of underground mines and exploration of copper porphyry targets. Held senior executive positions in several S&P companies in the United States and Latin America. Pecoy – Resource Statement Pecoy - Inferred Resources Cut-Off Tonnage Grade Contained % Cu M tonnes Cu % Mo % Au ppm Ag ppm B Lbs Cu 0.15 2,278 0.24 0.010 0.03 1.10 12,053 0.20 1,302 0.29 0.011 0.04 1.23 8,324 0.23 865 0.34 0.012 0.05 1.33 6,451 0.25 742 0.36 0.012 0.05 1.37 5,889 Notes: 1. Mineral Resources are not Mineral Reserves and have not demonstrated economic viability. 2. The MRE has been categorized in accordance with the CIM Definition Standards (CIM, 2014). 3. All figures are rounded to reflect the relative accuracy of the estimates. Minor discrepancies may occur due to rounding to appropriate significant figures. 4. The Mineral Resource was estimated by Ms. Muñoz QP (MAIG) of Mining Plus, Independent Qualified Person under NI 43-101. 5. The effective date of the Mineral Resource Estimate is 30 April 2025. 6. The Mineral Resource is reported inside a whittle pit shell with a cut-off grade of 0.23 % copper, estimated using a copper price of US$/lb 3.25, molybdenum price of US$ 8/lb, gold price of US$ 1,400/oz and silver price of US$ 20/oz. 7. Mining Plus is not aware of any legal, political, environmental, or other risks that could materially affect the potential development of the Mineral Resource Estimate Conditions to Closing The completion of the Transaction will be subject to a number of conditions customary for a transaction of this nature, including but not limited to entering into a definitive agreement in respect of the Transaction, the receipt of required regulatory and corporate approvals, approval of the Amalgamation by the shareholders of Pembrook, completion of the Acquisition Agreements; and the closing of the Offering. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. About the Pecoy Project The Pecoy Project covers an area of 9,975 hectares (ha) across 19 concessions without prior mining activity. The Project is located along the northwest extension of the Southern Peru Porphyry Copper Belt, a metallogenic corridor that hosts several large-scale porphyry copper deposits. The project area is underlain by intrusive rocks of the Coastal Batholith, including porphyritic granites and granodiorites, which are intruded by hydrothermal breccias, dacitic porphyries and multitude of dikes. Alteration consists of widespread sericitization (chlorite and sericite alteration) and silicification near the center of the system, grading downward to potassic and outward to propylitic alteration. Additionally, there are narrow gold-bearing quartz veins in the periphery of the system. Mineralization is associated with a porphyry copper system featuring well-developed supergene and primary zones, where copper occurs mainly as chalcocite and chalcopyrite. At surface, mineralization is almost totally oxidized. Leached, supergene, copper oxide, enrichment and transitional zones of the porphyry copper deposit are leached to a maximum depth of 200 to 240 m. The secondary enrichment zone has an average approximate thickness of 20 m, with a minimum of 2 meters and a maximum of 70 m. The primary mineralization extends to depths greater than 1,000 m, with significant copper and gold values hosted in breccia bodies and porphyritic intrusions and remains open laterally and at depth. The Pecoy Project is situated at the northwest end of the Southern Peru Porphyry Copper Belt which also hosts the large Cuajone, Toquepala, Quellaveco, Cerro Verde, Zafranal, and Cerro Negro porphyry deposits. Porphyry copper mineralization occurs above multi-phase intrusive complexes and can produce large tonnage, low grade copper deposits with possible by-products of gold and molybdenum. To date, the Pecoy Project includes 121 diamond drill holes totaling 48,576 m of drilling. Drilling has consistently intersected porphyry-style mineralization, with copper, gold, silver, and molybdenum values continuously distributed across the drilled area. The technical disclosure in this news release has been reviewed and approved by Vincent Cardin-Tremblay, P. Geo., who is a Qualified Person as defined by National Instrument 43-101 of the Canadian Securities Administrators. About the Company The Company is a reporting issuer in the Provinces of British Columbia and Alberta. The Company's shares are not currently listed on any stock exchange and it is presently engaged in identifying and evaluating potential business opportunities. ON BEHALF OF THE BOARD OF DIRECTORS Robert Dubeau, President, CEO and Director Suite 1500, 1055 West Georgia Street, Vancouver, BC V6E 4N7 Telephone: 778 837 8550 Email: bobbydubeau@ Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements that may be deemed "forward-looking statements". All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur and specifically include statements regarding the Transaction, the Amalgamation; the timing and potential completion of the Transaction; satisfaction of the conditions precedent to closing of the Transaction; the Name Change; the Board Re-Constitution; and the Company's business and strategic plans. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward looking statements. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change. SOURCE Pecoy Copper View original content:

Associated Press
15 minutes ago
- Associated Press
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event: Barclays Speaking the Science Call Series, on Monday, June 16th at 10:00am ET A live webcast of this presentation will be available under 'Events and Presentations' in the Investors section of the Moderna website. A replay of this webcast will be archived on Moderna's website for at least 30 days following the presentation. About Moderna Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations 617-209-5834 [email protected] SOURCE: Moderna, Inc. press release


Associated Press
15 minutes ago
- Associated Press
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC ™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact: Barbara Ryan [email protected] (203) 274-2825